Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7707-02-0

7-Benzolylaminoheptanoic acid is a complex organic compound with the chemical formula C14H18N2O2. It is a derivative of heptanoic acid, featuring a benzoyl group attached to the amino group, which is in turn connected to the heptanoic acid chain. 7-benzolylaminoheptanoic acid is characterized by its molecular structure that includes a seven-carbon aliphatic chain, an amino group, and a benzene ring. It is a white crystalline solid and is soluble in organic solvents. 7-Benzolylaminoheptanoic acid is not a common household or industrial chemical but may be found in specialized applications or as an intermediate in the synthesis of more complex molecules. Its properties and reactivity are influenced by the presence of the benzoyl group, which can participate in various chemical reactions, such as acylation or substitution reactions.

7707-02-0

Post Buying Request

7707-02-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7707-02-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7707-02-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,7,0 and 7 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 7707-02:
(6*7)+(5*7)+(4*0)+(3*7)+(2*0)+(1*2)=100
100 % 10 = 0
So 7707-02-0 is a valid CAS Registry Number.

7707-02-0Downstream Products

7707-02-0Relevant articles and documents

Novel hydroxyphenylurea dual inhibitor against Acyl-CoA: Cholesterol acyltransferase (ACAT) and low density lipoprotein (LDL) oxidation as antiatherosclerotic agent

Nakao, Kazuya,Kubota, Hitoshi,Yasuhara, Mikiko,Saito, Keiko,Suzuki, Toshikazu,Ohmizu, Hiroshi,Shimizu, Ryo

, p. 853 - 861 (2007/10/03)

Novel hydroxyphenylurea derivatives were synthesized and their inhibitory potency evaluated against acyl-CoA: cholesterol acyltransferase ACAT. Quantitative structure-activity relationship analysis revealed that their ACAT inhibitory activities were controlled by the hydrophobicity of the whole molecule, the substitution pattern of urea moiety, and the existence of carboxylic acid. The derivatives with strong activities inhibited foam cell formations. Moreover, these compounds showed antioxidative effects against low density lipoprotein LDL, owing to their characteristic 3-tert-butyl-2-hydroxy-5-methoxyphenyl substructure. Based on the mechanism of atherosclerosis generation, this hydroxyphenylurea-type dual inhibitor against both ACAT and LDL oxidation is expected to be a promising drug for atherosclerosis. Copyright

Potent inducers of terminal differentiation and method of use thereof

-

, (2008/06/13)

This invention is directed to compounds having the structure: STR1 wherein R1 and R2 are independently the same as or different from each other; when R1 and R2 are the same, each is a substituted or unsubstitute

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7707-02-0